StreetAlpha.app
Home › Stocks › GPCR

Structure Therapeutics Inc. (GPCR)

Healthcare
$16.13
▼ −5.78%
LAST CLOSE · NOV 20

Structure Therapeutics develops oral small molecule drugs that target G protein coupled receptors to treat chronic diseases, mainly obesity. It last closed at $16.13 on Nov 20, down 5.78% on the day. The next earnings report for GPCR is expected around Thu, Feb 25, 2027, after the close. For the quarter ended Sep 2026, GPCR reported EPS of -$0.66. Over its last 8 reports the stock moved an average of 2.1% the session after earnings.

AI Auto Pilots
Is GPCR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GPCR.

Key Stats

Last 12 months
Results
Net income
−$293.9M
EPS (diluted)
−$1.30
Free cash flow
−$277.3M
Valuation
Market cap
$3.5B
214.8M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$222.0M
At Sep 30
Shareholder equity
$1.2B
Shares outstanding
214.8M
At Oct 31
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2022: −$51.3M−$51.3MFY2022FY2023: −$89.6M−$89.6MFY2023FY2024: −$122.5M−$122.5MFY2024FY2025: −$141.2M−$141.2MFY2025

From GPCR's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Feb 25
Estimated date · After the close
Reported EPS
-$0.66
Quarter ended Sep 2026
Year ago EPS
-$0.37
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.22Dec '24Mar 2025: -$0.27Mar '25Jun 2025: -$0.36Jun '25Sep 2025: -$0.37Sep '25Dec 2025: $0.20Dec '25Mar 2026: -$0.35Mar '26Jun 2026: -$0.49Jun '26Sep 2026: -$0.66Sep '26Latest -$0.66
Revenue by quarter
Not enough quarters on file yet.
How GPCR moved after its last 8 reports
Average move the session after a report ±2.1%
Nov 9, 2026After the close+1.5%
Aug 6, 2026After the close+1.0%
May 7, 2026After the close−0.1%
Feb 26, 2026After the close−2.7%
Nov 6, 2025After the close−1.9%
Aug 6, 2025After the close−0.7%
May 8, 2025After the close−4.7%
Feb 27, 2025After the close+4.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on GPCRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on GPCR
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on GPCR

Technical Analysis

GPCR · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 24% below its 20 day and 58% below its 50 day average. It is 173% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the 52 week low at $16.06, and the nearest resistance the Pivot at $16.42.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 8.8%/day
Key levels
$94.9052 week high+488.3%
$43.96200 day average+172.5%
$37.62100 day average+133.2%
$25.4950 day average+58.0%
$22.36Swing high (Oct 30)+38.6%
$19.9920 day average+23.9%
$16.79Pivot R1+4.1%
$16.42Pivot+1.8%
$16.13Last close
$16.0652 week low−0.4%
$15.77Pivot S1−2.2%
Indicators
RSI (14)22.38Oversold below 30Oversold
MACD-2.34Above its signal lineBullish
Stochastic1.8Near the bottom of its rangeOversold
ADX (14)53.7Strong downtrend
Williams %R-99.0Oversold below −80, overbought above −20Oversold
CCI (20)-191.7Oversold below −100, overbought above 100Oversold
Rate of change−20.7%Change over 10 sessionsBearish
ATR (14)$1.41Typical daily range, 8.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for GPCR

What happened before

See how GPCR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow GPCR usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How GPCR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for GPCRHow many large options trades hit GPCR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

GPCR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼76 buying vs 106 selling
  • ●Held by funds +0.3 pts
  • ▼Funds holding -21
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding173194−10.8%
In funds' top 1028−75.0%
Held by funds31.8%31.5%+0.3 pts
New / increased26 / 5029 / 75−26.9%
Reduced / sold out61 / 4550 / 34+26.2%
Put/call ratio0.010.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See GPCR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GPCR is in one of them and how their past GPCR trades turned out.

GPCR in the AI portfolios
Loading…

GPCR News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered GPCR in an article yet. Here's the latest on the wider market.

GPCR in the news

GPCR Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Nov 2
Who traded GPCR · since 2023
Latest 1 filing
$1K – $15KTraded Oct 4, 2023Filed Nov 2, 2023
PersonTypeAmountTradedFiledDelay
Tom CarperD · DESell$1K – $15KOct 4, 2023Nov 2, 202329 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Structure Therapeutics

Structure Therapeutics is a biopharmaceutical company based in South San Francisco, California. It is developing oral small molecule drugs that act on G protein coupled receptors, a family of receptors that control many body processes. Its most advanced candidate is aimed at obesity, and its pipeline includes other candidates for metabolic and related conditions. The company is still in clinical development, and its medicines are intended for patients with chronic diseases.

Headquarters
South San Francisco, CA